The growing ability to modulate mRNA is reshaping drug discovery, offering researchers new approaches for diseases that have proven challenging to treat with conventional strategies.

During this webinar, Dr. Timur Samatov and Dr. Xavier Maréchal will explore how Evotec's high-throughput RT-qPCR platform and ScreenSeq transcriptomics solution work together to support mRNA-focused research. By combining rapid screening with comprehensive gene expression profiling, researchers can generate deeper biological insights while increasing throughput and scalability.

See how integrating transcriptomics throughout the discovery workflow can help accelerate the progression from early screening to candidate selection.

Key takeaways

• Learn how mRNA modulation is expanding the landscape of potential therapeutic targets.
• Explore the capabilities of multiplexed high-throughput RT-qPCR for screening up to 13,000 compounds per day.
• Understand how unbiased transcriptomic profiling enhances hit validation, lead expansion, and SAR analysis to provide richer context for RT-qPCR findings.